STOCKWATCH
·
Healthcare Service Provider
Acquisitions7 Aug 2025, 05:21 pm

Metropolis Healthcare Acquires Dr. RS Patil's Ambika Pathology Laboratory and Reports Q1 Results

AI Summary

Metropolis Healthcare Ltd. has announced the acquisition of Dr. RS Patil's Ambika Pathology Laboratory in Kolhapur, Maharashtra, through a Business Transfer Agreement (BTA). The acquisition is contingent upon the fulfillment of certain conditions precedent outlined in the BTA. The company also reported its un-audited standalone and consolidated financial results for the quarter ended June 30, 2025, with a noted limited review report from the Statutory Auditors.

Key Highlights

  • Acquisition of Dr. RS Patil's Ambika Pathology Laboratory on a slump sale basis
  • Completion of acquisition subject to fulfillment of conditions precedent
  • Approval of un-audited standalone and consolidated financial results for Q1 2025
  • Limited review report issued by Statutory Auditors
  • Financial results available on company's website
METROPOLIS
Healthcare Service Provider
Metropolis Healthcare Ltd

Price Impact